ARTICLE | Clinical News
Renagel sevelamer hydrochloride regulatory update
November 10, 2008 8:00 AM UTC
Kyowa Hakko Kirin disclosed that in June the company submitted a marketing application in China for Phosblock to treat hyperphosphatemia. The company licensed Chinese rights to the non-absorbed phosph...